PLET1
Placenta-expressed transcript 1 protein
Also known as: C11orf34, PLET1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q6UQ28
- Gene
- PLET1
- Ensembl
- ENSG00000188771
- Chromosome
- 11
- Canonical length
- 207 aa
- Protein class
- Predicted membrane proteins
OverviewNCBI Gene
Predicted to be involved in negative regulation of cell-matrix adhesion; positive regulation of cell migration; and wound healing, spreading of epidermal cells. Predicted to be located in extracellular region and plasma membrane. Predicted to be active in apical plasma membrane and external side of plasma membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
207 residues, UniProt reviewed canonical sequence.
>Q6UQ28|PLET1
1 MAVFHDMLLQ PLGMFLCLSL QLSSATFIRY SSTCFTFDEY YTITLDIKAS SHIYESNAVY
61 SVFVPVNDSV YAVVMKTLDE NSDSAGLWQR ADKNCYSNST YYVKDQYMTV LEAQWQAPEP
121 ENITEVEIQA FTVQIRALPI LSTLKLREKL STLALAAKIP QSSAFKPFFM ITPKSIRLEG
181 LANQVFSSPI TEAIYILLAF LTSTLLFLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PLET1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.43
- Highest tissue expression
- 0.2 nTPM
Expression across tissuesHPA
Tissue
- skin: 0.2 nTPM
- bone marrow: 0.1 nTPM
- pituitary gland: 0.1 nTPM
- retina: 0.1 nTPM
- adipose tissue: 0 nTPM
- adrenal gland: 0 nTPM
Single-cell type
- epicardial cells: 61 nCPM
- retinal ganglion cells: 35 nCPM
- retinal horizontal cells: 32 nCPM
- retinal bipolar cells: 25 nCPM
- hepatic stellate cells: 19 nCPM
- rod photoreceptor cells: 19 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebellum: 2.9 nTPM
- hypothalamus: 2.6 nTPM
- pons: 2.3 nTPM
- medulla oblongata: 2.1 nTPM
- white matter: 2.1 nTPM
- thalamus: 2 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.67
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.84
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell differentiation
- negative regulation of cell-matrix adhesion
- positive regulation of cell migration
- wound healing, spreading of epidermal cells
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Placenta-expressed transcript 1
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PLET1 as an antibody target. Whether an autoantibody or antibody against PLET1 could matter depends on whether native PLET1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PLET1 is annotated at the cell surface, where native PLET1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label PLET1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...